UBS Global Research has upgraded Orior to “neutral” from “sell,” suggesting the stock's weak performance is already factored into its price. The Swiss food company's shares have been declining, prompting UBS to believe there's limited further downside. The firm also lowered its 12-month price target, reflecting updated earnings forecasts and valuation adjustments.

UBS's assessment points to a challenging operating environment. Investor sentiment has been dampened by muted performance and high debt levels. The brokerage is concerned about the company's leverage, with a net debt-to-EBITDA ratio estimated at 4.1x in 2025. Intense competition in Switzerland and risks from retailer insourcing contribute to the bearish outlook.

Potential divestment of Culinor, which could generate significant proceeds, is viewed as a positive. UBS estimates these proceeds could reduce net debt to around CHF90 million to CHF100 million. The bank expects organic sales to fall in 2026, though the EBITDA margin is expected to remain flat. Customer concentration with Migros remains a key concern.

What's next for Orior? Investors should monitor the progress of the Culinor divestment, which could reshape the company's financial profile. Market participants will also be watching Orior's ability to navigate the competitive Swiss market and manage its customer relationships, particularly with its largest client, Migros.